245 related articles for article (PubMed ID: 28918053)
21. The USH2A c.2299delG mutation: dating its common origin in a Southern European population.
Aller E; Larrieu L; Jaijo T; Baux D; Espinós C; González-Candelas F; Nájera C; Palau F; Claustres M; Roux AF; Millán JM
Eur J Hum Genet; 2010 Jul; 18(7):788-93. PubMed ID: 20145675
[TBL] [Abstract][Full Text] [Related]
22. The usher syndromes.
Keats BJ; Corey DP
Am J Med Genet; 1999 Sep; 89(3):158-66. PubMed ID: 10704190
[TBL] [Abstract][Full Text] [Related]
23. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
Ebermann I; Scholl HP; Charbel Issa P; Becirovic E; Lamprecht J; Jurklies B; Millán JM; Aller E; Mitter D; Bolz H
Hum Genet; 2007 Apr; 121(2):203-11. PubMed ID: 17171570
[TBL] [Abstract][Full Text] [Related]
24. The Genetics of Usher Syndrome in the Israeli and Palestinian Populations.
Khalaileh A; Abu-Diab A; Ben-Yosef T; Raas-Rothschild A; Lerer I; Alswaiti Y; Chowers I; Banin E; Sharon D; Khateb S
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1095-1104. PubMed ID: 29490346
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
[TBL] [Abstract][Full Text] [Related]
26. Targeted next generation sequencing for molecular diagnosis of Usher syndrome.
Aparisi MJ; Aller E; Fuster-García C; García-García G; Rodrigo R; Vázquez-Manrique RP; Blanco-Kelly F; Ayuso C; Roux AF; Jaijo T; Millán JM
Orphanet J Rare Dis; 2014 Nov; 9():168. PubMed ID: 25404053
[TBL] [Abstract][Full Text] [Related]
27. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
[TBL] [Abstract][Full Text] [Related]
28. Site-directed mutagenesis in Petunia × hybrida protoplast system using direct delivery of purified recombinant Cas9 ribonucleoproteins.
Subburaj S; Chung SJ; Lee C; Ryu SM; Kim DH; Kim JS; Bae S; Lee GJ
Plant Cell Rep; 2016 Jul; 35(7):1535-44. PubMed ID: 26825596
[TBL] [Abstract][Full Text] [Related]
29. Detecting novel mutations and combined Klinefelter syndrome in Usher syndrome cases.
Li X; Huang S; Yuan Y; Lu Y; Zhang D; Wang X; Yuan H; Han W; Dai P
Acta Otolaryngol; 2019 Jun; 139(6):479-486. PubMed ID: 31035849
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
31. Genetic screening of Russian Usher syndrome patients toward selection for gene therapy.
Ivanova ME; Trubilin VN; Atarshchikov DS; Demchinsky AM; Strelnikov VV; Tanas AS; Orlova OM; Machalov AS; Overchenko KV; Markova TV; Golenkova DM; Anoshkin KI; Volodin IV; Zaletaev DV; Pulin AA; Nadelyaeva II; Kalinkin AI; Barh D
Ophthalmic Genet; 2018 Dec; 39(6):706-713. PubMed ID: 30358468
[TBL] [Abstract][Full Text] [Related]
32. A Simple and Universal System for Gene Manipulation in
Al Abdallah Q; Ge W; Fortwendel JR
mSphere; 2017; 2(6):. PubMed ID: 29202040
[TBL] [Abstract][Full Text] [Related]
33. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
[TBL] [Abstract][Full Text] [Related]
34. Efficacy Outcome Measures for Clinical Trials of USH2A Caused by the Common c.2299delG Mutation.
Calzetti G; Levy RA; Cideciyan AV; Garafalo AV; Roman AJ; Sumaroka A; Charng J; Heon E; Jacobson SG
Am J Ophthalmol; 2018 Sep; 193():114-129. PubMed ID: 29953849
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
Farooq R; Hussain K; Nazir S; Javed MR; Masood N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
[TBL] [Abstract][Full Text] [Related]
36. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
37. Use of RNA-Protein Complexes for Genome Editing in Non-
Grahl N; Demers EG; Crocker AW; Hogan DA
mSphere; 2017; 2(3):. PubMed ID: 28657070
[TBL] [Abstract][Full Text] [Related]
38. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
39. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
[TBL] [Abstract][Full Text] [Related]
40. Targeted next generation sequencing in Italian patients with Usher syndrome: phenotype-genotype correlations.
Eandi CM; Dallorto L; Spinetta R; Micieli MP; Vanzetti M; Mariottini A; Passerini I; Torricelli F; Alovisi C; Marchese C
Sci Rep; 2017 Nov; 7(1):15681. PubMed ID: 29142287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
